Oncology
Conference Coverage
Osimertinib improves survival in advanced NSCLC
BARCELONA – Osimertinib is the first TKI to show a survival advantage over another in advanced non–small cell lung cancer, FLAURA investigators...
Latest News
Mortality after breast cancer diagnosis found higher for men
Male patients had 19% higher 5-year mortality than their female counterparts even after confounders were taken into account.
News
FDA issues warning for CDK 4/6 inhibitors
In a review of trials and postmarket safety databases, the FDA found there were reports of serious cases of pneumonitis, including fatalities,...
Digital Edition
Abstracts Presented at the 2019 AVAHO Annual Meeting
September 20-22, 2019 ► Minneapolis, MI
Conference Coverage
New IASLC declaration targets tobacco use among cancer patients
BARCELONA – The IASLC has released a new declaration encouraging physicians to screen all cancer patients for tobacco use and to provide tobacco...
Article
Cancer in the VA: The Big Picture
Article
Surviving Colorectal Cancer, Now at Risk for Hypertension
Are patients more at risk for hypertension and diabetes mellitus after surviving colorectal cancer? VA researchers investigate.
Clinical Topics & News
Open Clinical Trials for Patients With Lung Cancers
News
HIV drug may enhance efficacy of chemoradiation in locally advanced lung cancer
Strategy incorporating protease inhibitor nelfinavir yields promising efficacy, acceptable toxicity in locally advanced non–small cell lung cancer...
